Report Cover

Global and China Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2021-2027


Global Spinal Muscular Atrophy (SMA) Treatment Scope and Market Size
Spinal Muscular Atrophy (SMA) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy (SMA) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Type I Spinal Muscular Atrophy (SMA)
    Type II Spinal Muscular Atrophy (SMA)
    Type III Spinal Muscular Atrophy (SMA)

Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    Pfizer
    Isis Pharmaceuticals
    Biogen Idec
    Boehringer Ingelheim
    F. Hoffmann-La Roche
    Regeneron Pharmaceuticals
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Type I Spinal Muscular Atrophy (SMA)
        1.2.3 Type II Spinal Muscular Atrophy (SMA)
        1.2.4 Type III Spinal Muscular Atrophy (SMA)
    1.3 Market by Application
        1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Perspective (2016-2027)
    2.2 Spinal Muscular Atrophy (SMA) Treatment Growth Trends by Regions
        2.2.1 Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Spinal Muscular Atrophy (SMA) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Spinal Muscular Atrophy (SMA) Treatment Industry Dynamic
        2.3.1 Spinal Muscular Atrophy (SMA) Treatment Market Trends
        2.3.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers
        2.3.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges
        2.3.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue
        3.1.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Treatment Revenue
    3.4 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio
        3.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2020
    3.5 Spinal Muscular Atrophy (SMA) Treatment Key Players Head office and Area Served
    3.6 Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
    3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Type
    4.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2022-2027)

5 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Application
    5.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
    6.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        6.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
    6.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        6.3.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
    6.4 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        6.4.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
    7.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        7.2.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
    7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        7.3.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
    7.4 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        7.4.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region
        8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
    9.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        9.2.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        9.3.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        9.4.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
        10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
        10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
        10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.1.4 Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Isis Pharmaceuticals
        11.2.1 Isis Pharmaceuticals Company Details
        11.2.2 Isis Pharmaceuticals Business Overview
        11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.2.4 Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
        11.2.5 Isis Pharmaceuticals Recent Development
    11.3 Biogen Idec
        11.3.1 Biogen Idec Company Details
        11.3.2 Biogen Idec Business Overview
        11.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.3.4 Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
        11.3.5 Biogen Idec Recent Development
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Company Details
        11.4.2 Boehringer Ingelheim Business Overview
        11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.4.4 Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
        11.4.5 Boehringer Ingelheim Recent Development
    11.5 F. Hoffmann-La Roche
        11.5.1 F. Hoffmann-La Roche Company Details
        11.5.2 F. Hoffmann-La Roche Business Overview
        11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.5.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
        11.5.5 F. Hoffmann-La Roche Recent Development
    11.6 Regeneron Pharmaceuticals
        11.6.1 Regeneron Pharmaceuticals Company Details
        11.6.2 Regeneron Pharmaceuticals Business Overview
        11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
        11.6.4 Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
        11.6.5 Regeneron Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Type I Spinal Muscular Atrophy (SMA) Table 3. Key Players of Type II Spinal Muscular Atrophy (SMA) Table 4. Key Players of Type III Spinal Muscular Atrophy (SMA) Table 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions (2016-2021) Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions (2022-2027) Table 11. Spinal Muscular Atrophy (SMA) Treatment Market Trends Table 12. Spinal Muscular Atrophy (SMA) Treatment Market Drivers Table 13. Spinal Muscular Atrophy (SMA) Treatment Market Challenges Table 14. Spinal Muscular Atrophy (SMA) Treatment Market Restraints Table 15. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players (2016-2021) Table 17. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2020) Table 18. Ranking of Global Top Spinal Muscular Atrophy (SMA) Treatment Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service Table 22. Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million) Table 25. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2016-2021) Table 26. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2016-2021) Table 30. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million) Table 33. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million) Table 35. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Table 65. Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Isis Pharmaceuticals Company Details Table 68. Isis Pharmaceuticals Business Overview Table 69. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Table 70. Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million) Table 71. Isis Pharmaceuticals Recent Development Table 72. Biogen Idec Company Details Table 73. Biogen Idec Business Overview Table 74. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Table 75. Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million) Table 76. Biogen Idec Recent Development Table 77. Boehringer Ingelheim Company Details Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Table 80. Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million) Table 81. Boehringer Ingelheim Recent Development Table 82. F. Hoffmann-La Roche Company Details Table 83. F. Hoffmann-La Roche Business Overview Table 84. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Table 85. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million) Table 86. F. Hoffmann-La Roche Recent Development Table 87. Regeneron Pharmaceuticals Company Details Table 88. Regeneron Pharmaceuticals Business Overview Table 89. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Table 90. Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million) Table 91. Regeneron Pharmaceuticals Recent Development Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type: 2020 VS 2027 Figure 2. Type I Spinal Muscular Atrophy (SMA) Features Figure 3. Type II Spinal Muscular Atrophy (SMA) Features Figure 4. Type III Spinal Muscular Atrophy (SMA) Features Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Ambulatory Surgical Centers Case Studies Figure 8. Diagnostic Centers Case Studies Figure 9. Others Case Studies Figure 10. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered Figure 11. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions: 2020 VS 2027 Figure 14. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions (2022-2027) Figure 15. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players in 2020 Figure 16. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2020 Figure 18. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2016-2021) Figure 19. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2022-2027) Figure 20. North America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027) Figure 22. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027) Figure 23. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027) Figure 24. United States Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027) Figure 28. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027) Figure 29. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027) Figure 30. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027) Figure 38. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027) Figure 39. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2016-2027) Figure 40. China Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027) Figure 48. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027) Figure 49. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027) Figure 50. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027) Figure 54. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027) Figure 55. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027) Figure 56. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Pfizer Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) Figure 60. Isis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) Figure 61. Biogen Idec Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) Figure 62. Boehringer Ingelheim Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us